{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:56:07Z","timestamp":1792526167749,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.vascn.2022.107171","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T19:21:12Z","timestamp":1649272872000},"page":"107171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["An integrative pharmacokinetic-cardiovascular physiology modelling approach based on in vivo dog studies including five reference compounds"],"prefix":"10.1016","volume":"115","author":[{"given":"Mikael","family":"Wallman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Markus","family":"Borghardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Pairet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Markert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Jirstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vascn.2022.107171_bb0005","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/chir.530050608","article-title":"Pharmacokinetics of the enantiomers of verapamil in the dog","volume":"5","author":"Bai","year":"1993","journal-title":"Chirality"},{"issue":"2","key":"10.1016\/j.vascn.2022.107171_bb0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00003495-199855020-00016","article-title":"Formoterol: An update of its pharmacological properties and therapeutic efficacy in the Management of Asthma","volume":"55","author":"Bartow","year":"1998","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.vascn.2022.107171_bb0015","first-page":"353","article-title":"An analysis of the time-relations of electrocardiograms","volume":"7","author":"Bazett","year":"1920","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.vascn.2022.107171_bb0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/jvp.12235","article-title":"The pharmacokinetics of pimobendan enantiomers after oral and intravenous administration of racemate pimobendan formulations in healthy dogs","volume":"39","author":"Bell","year":"2016","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"issue":"4","key":"10.1016\/j.vascn.2022.107171_bb0025","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/01.RES.55.4.440","article-title":"Changes in vascular capacity in awake dogs in response to carotid sinus occlusion and administration of catecholamines","volume":"55","author":"Bennett","year":"1984","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/j.vascn.2022.107171_bb0030","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/toxsci\/kfz035","article-title":"Preclinical to clinical translation of hemodynamic effects in cardiovascular safety pharmacology studies","volume":"169","author":"Bhatt","year":"2019","journal-title":"Toxicological Sciences: An Official Journal of the Society of Toxicology"},{"issue":"3","key":"10.1016\/j.vascn.2022.107171_bb0035","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/bcp.12780","article-title":"Investigating pulmonary and systemic pharmacokinetics of inhaled olodaterol in healthy volunteers using a population pharmacokinetic approach","volume":"81","author":"Borghardt","year":"2016","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"4","key":"10.1016\/j.vascn.2022.107171_bb0040","first-page":"763","article-title":"Higher lung deposition with Respimat\u00ae soft mistTM inhaler than HFA-MDI in COPD patients with poor technique","volume":"3","author":"Brand","year":"2008","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"2","key":"10.1016\/j.vascn.2022.107171_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.vascn.2008.11.001","article-title":"Calculation of QT shift in non clinical safety pharmacology studies","volume":"59","author":"Champeroux","year":"2009","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"9","key":"10.1016\/j.vascn.2022.107171_bb0050","first-page":"696","article-title":"Pharmacokinetics interaction of captopril and low-dosage aspirin in dog","volume":"40","author":"Chen","year":"2005","journal-title":"Journal of Chinese Pharmaceutical Sciences"},{"issue":"6","key":"10.1016\/j.vascn.2022.107171_bb0055","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd4309","article-title":"Lessons learned from the fate of AstraZeneca\u2019s drug pipeline: A five-dimensional framework","volume":"13","author":"Cook","year":"2014","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"3","key":"10.1016\/j.vascn.2022.107171_bb0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1939-1676.1998.tb02107.x","article-title":"Calcium Channel blockers in veterinary medicine","volume":"12","author":"Cooke","year":"1998","journal-title":"Journal of Veterinary Internal Medicine"},{"issue":"2","key":"10.1016\/j.vascn.2022.107171_bb0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/1467-9868.00179","article-title":"Gibbs sampling for Bayesian non-conjugate and hierarchical models by using auxiliary variables","volume":"61","author":"Damlen","year":"1999","journal-title":"Journal of the Royal Statistical Society: Series B (Statistical Methodology)"},{"issue":"4","key":"10.1016\/j.vascn.2022.107171_bb0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2165\/00003088-198814040-00002","article-title":"Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases","volume":"14","author":"Duchin","year":"1988","journal-title":"Clinical Pharmacokinetics"},{"issue":"5","key":"10.1016\/j.vascn.2022.107171_bb0075","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0090-9556(25)06622-X","article-title":"An improved pharmacodynamic model for formation of methemoglobin by antimalarial drugs","volume":"23","author":"Fasanmade","year":"1995","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"issue":"202","key":"10.1016\/j.vascn.2022.107171_bb0080","first-page":"61134","article-title":"International conference on harmonisation; guidance on E14 clinical evaluation of QT\/QTc interval prolongation and Proarrhythmic potential for non-antiarrhythmic drugs; availability. Notice","volume":"70","author":"Food and Drug Administration, HHS","year":"2005","journal-title":"Federal Register"},{"issue":"2","key":"10.1016\/j.vascn.2022.107171_bb0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2125.2005.02546.x","article-title":"Pharmacokinetic\u2013pharmacodynamic modelling of QT interval prolongation following citalopram overdoses","volume":"61","author":"Friberg","year":"2006","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1016\/j.vascn.2022.107171_bb0090","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.0954-6820.1920.tb18266.x","article-title":"Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken","volume":"53","author":"Fridericia","year":"1920","journal-title":"Acta Medica Scandinavica"},{"key":"10.1016\/j.vascn.2022.107171_bb0095","series-title":"Small animal clinical pharmacology (second edition) (pp. 380\u2013457)","article-title":"Chapter 17\u2014Drugs used in the management of heart disease and cardiac arrhythmias","author":"Gordon","year":"2008"},{"issue":"3","key":"10.1016\/j.vascn.2022.107171_bb0100","first-page":"147","article-title":"Translational model to predict pulmonary pharmacokinetics and efficacy in man for inhaled bronchodilators. CPT: Pharmacometrics & Systems","volume":"7","author":"Hendrickx","year":"2018","journal-title":"Pharmacology"},{"key":"10.1016\/j.vascn.2022.107171_bb0105","series-title":"Levick\u2019s introduction to cardiovascular physiology","author":"Herring","year":"2018"},{"key":"10.1016\/j.vascn.2022.107171_bb0110","first-page":"694","article-title":"Bazett\u2019s QT correction reviewed: Evidence that a linear QT correction for heart rate is better","volume":"1","author":"Hodges","year":"1983","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1016\/j.vascn.2022.107171_bb0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.vascn.2006.05.007","article-title":"Novel probabilistic method for precisely correcting the QT interval for heart rate in telemetered dogs and cynomolgus monkeys","volume":"55","author":"Holzgrefe","year":"2007","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"1","key":"10.1016\/j.vascn.2022.107171_bb0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.vascn.2013.05.004","article-title":"Preclinical QT safety assessment: Cross-species comparisons and human translation from an industry consortium","volume":"69","author":"Holzgrefe","year":"2014","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"1","key":"10.1016\/j.vascn.2022.107171_bb0125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1152\/ajplegacy.1958.196.1.193","article-title":"Evaluation of variability in the cardiac output of dogs","volume":"196","author":"Howell","year":"1958","journal-title":"American Journal of Physiology-Legacy Content"},{"issue":"1","key":"10.1016\/j.vascn.2022.107171_bb0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/clpt.1981.4","article-title":"Verapamil protein binding in patients and in normal subjects","volume":"29","author":"Keefe","year":"1981","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"4","key":"10.1016\/j.vascn.2022.107171_bb0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1527-3466.1988.tb00380.x","article-title":"Pimobendan","volume":"6","author":"Kitzen","year":"1988","journal-title":"Cardiovascular Drug Reviews"},{"issue":"2","key":"10.1016\/j.vascn.2022.107171_bb0140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.vascn.2006.03.010","article-title":"Optimizing the experimental environment for dog telemetry studies","volume":"54","author":"Klumpp","year":"2006","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"4","key":"10.1016\/j.vascn.2022.107171_bb0145","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1476-5381.2011.01255.x","article-title":"How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?","volume":"163","author":"Laverty","year":"2011","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.vascn.2022.107171_bb0150","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00005344-199103000-00009","article-title":"Captopril-induced reversal of nitroglycerin tolerance: Role of sulfhydryl group vs. ACE-inhibitory activity","volume":"17","author":"Lawson","year":"1991","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"1","key":"10.1016\/j.vascn.2022.107171_bb0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1258\/la.2007.007085","article-title":"Comparative study of heart rate variability between healthy human subjects and healthy dogs, rabbits and calves","volume":"43","author":"Manzo","year":"2009","journal-title":"Laboratory Animals"},{"issue":"2","key":"10.1016\/j.vascn.2022.107171_bb0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.vascn.2004.03.006","article-title":"A novel propellant-free inhalation drug delivery system for cardiovascular drug safety evaluation in conscious dogs","volume":"50","author":"Markert","year":"2004","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"3","key":"10.1016\/j.vascn.2022.107171_bb0165","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1128\/AAC.46.3.938-939.2002","article-title":"Importance of species selection in Arrythmogenic models of Q-T interval prolongation","volume":"46","author":"McDermott","year":"2002","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"12","key":"10.1016\/j.vascn.2022.107171_bb0170","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00392-019-01466-2","article-title":"Heart rate, mortality, and the relation with clinical and subclinical cardiovascular diseases: Results from the Gutenberg health study","volume":"108","author":"M\u00fcnzel","year":"2019","journal-title":"Clinical Research in Cardiology"},{"issue":"1","key":"10.1016\/j.vascn.2022.107171_bb0176","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-3565(24)36774-6","article-title":"The Cardiac Effects of Pimobendan (But Not Amrinone) Are Preserved at Rest and During Exercise in Conscious Dogs with Pacing-Induced Heart Failure","volume":"282","author":"Ohte","year":"1997","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/j.vascn.2022.107171_bb0175","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.vascn.2013.03.007","article-title":"Translational pharmacokinetic-pharmacodynamic modeling of QTc effects in dog and human","volume":"68","author":"Parkinson","year":"2013","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"3","key":"10.1016\/j.vascn.2022.107171_bb0180","doi-asserted-by":"crossref","first-page":"E609","DOI":"10.1208\/aapsj070363","article-title":"Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT\/QTc prolongation","volume":"7","author":"Piotrovsky","year":"2005","journal-title":"The AAPS Journal"},{"issue":"3","key":"10.1016\/j.vascn.2022.107171_bb0185","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0163-7258(95)02063-2","article-title":"Which cardiac potassium channel subtype is the preferable target for suppression of ventricular arrhythmias?","volume":"69","author":"Rees","year":"1996","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.vascn.2022.107171_bb0190","author":"Rohatgi"},{"issue":"7","key":"10.1016\/j.vascn.2022.107171_bb0195","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0002-9149(92)90562-D","article-title":"An improved method for adjusting the QT interval for heart rate (the Framingham heart study)","volume":"70","author":"Sagie","year":"1992","journal-title":"The American Journal of Cardiology"},{"issue":"12","key":"10.1016\/j.vascn.2022.107171_bb0200","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/00498258209038952","article-title":"Disposition and metabolism of formoterol fumarate, a new bronchodilator, in rats and dogs","volume":"12","author":"Sasaki","year":"1982","journal-title":"Xenobiotica; the Fate of Foreign Compounds in Biological Systems"},{"issue":"10","key":"10.1016\/j.vascn.2022.107171_bb0205","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/jps.2600701005","article-title":"Pharmacokinetics of captopril in dogs and monkeys","volume":"70","author":"Singhvi","year":"1981","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"6","key":"10.1016\/j.vascn.2022.107171_bb0210","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3109\/00498259209053133","article-title":"Pharmacokinetics and metabolism of dofetilide in mouse, rat, dog and man","volume":"22","author":"Smith","year":"1992","journal-title":"Xenobiotica"},{"issue":"22","key":"10.1016\/j.vascn.2022.107171_bb0215","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1111\/bph.12824","article-title":"Drug effects on the CVS in conscious rats: Separating cardiac output into heart rate and stroke volume using PKPD modelling","volume":"171","author":"Snelder","year":"2014","journal-title":"British Journal of Pharmacology"},{"issue":"7","key":"10.1016\/j.vascn.2022.107171_bb0220","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/bph.12190","article-title":"PKPD modelling of the interrelationship between mean arterial BP, cardiac output and total peripheral resistance in conscious rats","volume":"169","author":"Snelder","year":"2013","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.vascn.2022.107171_bb0225","doi-asserted-by":"crossref","DOI":"10.1097\/00006205-198604000-00006","article-title":"Review of Calcium-Channel Blockers","volume":"11","author":"Stowe","year":"1986","journal-title":"The Nurse Practitioner"},{"issue":"5220","key":"10.1016\/j.vascn.2022.107171_bb0230","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.7604285","article-title":"HERG, a human inward rectifier in the voltage-gated Potassium Channel family","volume":"269","author":"Trudeau","year":"1995","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vascn.2022.107171_bb0235","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0160-5402(89)90015-6","article-title":"An improved method to correct the QT interval of the electrocardiogram for changes in heart rate","volume":"22","author":"Van de Water","year":"1989","journal-title":"Journal of Pharmacological Methods"},{"issue":"15","key":"10.1016\/j.vascn.2022.107171_bb0240","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1111\/bph.15079","article-title":"Semi-mechanistic modelling platform to assess cardiac contractility and haemodynamics in preclinical cardiovascular safety profiling of new molecular entities","volume":"177","author":"Venkatasubramanian","year":"2020","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2022.107171_bb0245","article-title":"Dog-PKCV","author":"Wallman","year":"2021","journal-title":"GitHub"},{"key":"10.1016\/j.vascn.2022.107171_bb0250","series-title":"Dog-PKCV-Data. Mendeley Data","author":"Wallman","year":"2021"},{"key":"10.1016\/j.vascn.2022.107171_bb0255","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.120.000348","article-title":"An integrative approach for improved assessment of cardiovascular safety data","author":"Wallman","year":"2021","journal-title":"The Journal of Pharmacology and Experimental Therapeutics."},{"issue":"1","key":"10.1016\/j.vascn.2022.107171_bb0260","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/jvp.12243","article-title":"Pharmacokinetics and cardiovascular effects following a single oral administration of a nonaqueous pimobendan solution in healthy dogs","volume":"39","author":"Yata","year":"2016","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871922000181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871922000181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:05:36Z","timestamp":1761005136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871922000181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":53,"alternative-id":["S1056871922000181"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2022.107171","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An integrative pharmacokinetic-cardiovascular physiology modelling approach based on in vivo dog studies including five reference compounds","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2022.107171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107171"}}